iPSC reprogramming of fibroblasts from a patient with a Rothmund-Thomson syndrome RTS
Copyright © 2020. Published by Elsevier B.V..
Rothmund-Thomson Syndrome (RTS) is a rare autosomal recessive disease that manifests several clinical features of accelerated aging. These findings include atrophic skin and pigment changes, alopecia, osteopenia, cataracts, and an increased incidence of cancer for patients. Mutations in RECQL4 gene are responsible for cases of RTS. RECQL4 belongs to the RECQ DNA helicase family which has been shown to participate in many aspects of DNA metabolism. To be able to study the cellular defects related to the pathology, we derived an induced pluripotent cell line from RTS patient fibroblasts, with the ability to re-differentiate into the three embryonic germ layers.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Stem cell research - 45(2020) vom: 30. Mai, Seite 101807 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gatinois, Vincent [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 21.06.2021 Date Revised 21.06.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.scr.2020.101807 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309992303 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309992303 | ||
| 003 | DE-627 | ||
| 005 | 20231225135127.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.scr.2020.101807 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1033.xml |
| 035 | |a (DE-627)NLM309992303 | ||
| 035 | |a (NLM)32416578 | ||
| 035 | |a (PII)S1873-5061(20)30109-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gatinois, Vincent |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a iPSC reprogramming of fibroblasts from a patient with a Rothmund-Thomson syndrome RTS |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.06.2021 | ||
| 500 | |a Date Revised 21.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020. Published by Elsevier B.V. | ||
| 520 | |a Rothmund-Thomson Syndrome (RTS) is a rare autosomal recessive disease that manifests several clinical features of accelerated aging. These findings include atrophic skin and pigment changes, alopecia, osteopenia, cataracts, and an increased incidence of cancer for patients. Mutations in RECQL4 gene are responsible for cases of RTS. RECQL4 belongs to the RECQ DNA helicase family which has been shown to participate in many aspects of DNA metabolism. To be able to study the cellular defects related to the pathology, we derived an induced pluripotent cell line from RTS patient fibroblasts, with the ability to re-differentiate into the three embryonic germ layers | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Desprat, Romain |e verfasserin |4 aut | |
| 700 | 1 | |a Pichard, Lydiane |e verfasserin |4 aut | |
| 700 | 1 | |a Becker, Fabienne |e verfasserin |4 aut | |
| 700 | 1 | |a Goldenberg, Alice |e verfasserin |4 aut | |
| 700 | 1 | |a Balguerie, Xavier |e verfasserin |4 aut | |
| 700 | 1 | |a Pellestor, Franck |e verfasserin |4 aut | |
| 700 | 1 | |a Lemaitre, Jean-Marc |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Stem cell research |d 2007 |g 45(2020) vom: 30. Mai, Seite 101807 |w (DE-627)NLM18622009X |x 1876-7753 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2020 |g day:30 |g month:05 |g pages:101807 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.scr.2020.101807 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2020 |b 30 |c 05 |h 101807 | ||